| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $198.5M | -5.4% |
| Cost of Revenue | $165.5M | +1.1% |
| Gross Profit | $33.0M | -28.4% |
| R&D Expense | $45.1M | -2.3% |
| SG&A Expense | $49.3M | +7.3% |
| Operating Income | -$65.6M | -40.3% |
| Pre-tax Income | -$60.9M | -42.7% |
| Income Tax | -$76K | +92.2% |
| Net Income | -$60.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.8M | +23.7% |
| Accounts Receivable | $34.9M | -11.8% |
| Inventory | $40.8M | -21.8% |
| Current Assets | $194.1M | -12.0% |
| Total Assets | $270.2M | -11.9% |
| Current Liabilities | $34.2M | +4.5% |
| Total Liabilities | $53.8M | +2.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.4M | -123.4% |
| Capital Expenditures | $7.9M | +48.6% |
| Investing Cash Flow | $16.7M | +218.4% |
| Financing Cash Flow | -$1.3M | -51.7% |
| Free Cash Flow | -$10.3M | -316.6% |
| -45.9% |
| EPS (Basic) | -$1.27 | -41.1% |
| EPS (Diluted) | -$1.27 | -41.1% |
| Stockholders' Equity |
| $216.4M |
| -14.9% |